White Matter Lesions Predominantly Located in Deep White Matter Represent Embolic Etiology Rather Than Small Vessel Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose: We investigated the correlation between the deep distribution of white matter hyperintensity (WMH) (dWMH: WMH in deep and corticomedullary areas, with minimal periventricular WMH) and a positive agitated saline contrast echocardiography result. Methods: We retrospectively recruited participants with comprehensive dementia evaluations, an agitated saline study, and brain imaging. The participants were classified into two groups according to WMH-distributions: dWMH and dpWMH (mainly periventricular WMH with or without deep WMH.) We hypothesized that dWMH is more likely associated with embolism, whereas dpWMH is associated with small-vessel diseases. We compared the clinical characteristics, WMH-distributions, and positive rate of agitated saline studies between the two groups. Results: Among 90 participants, 27 and 12 met the dWMH and dpWMH criteria, respectively. The dWMH-group was younger (62.2±7.5 vs. 78.9±7.3, p<0.001) and had a lower prevalence of hypertension (29.6% vs. 75%, p=0.008), diabetes mellitus (3.7% vs. 25%, p=0.043), and hyperlipidemia (33.3% vs. 83.3%, p=0.043) than the dpWMH-group. Regarding deep white matter lesions, the number of small lesions (<3 mm) was higher in the dWMH-group(10.9±9.7) than in the dpWMH-group (3.1±6.4) (p=0.008), and WMH was predominantly distributed in the border-zones and corticomedullary areas. Most importantly, the positive agitated saline study rate was higher in the dWMH-group than in the dpWMH-group (81.5% vs. 33.3%, p=0.003). Conclusions: The dWMH-group with younger participants had fewer cardiovascular risk factors, showed more border-zone-distributions, and had a higher agitated saline test positivity rate than the dpWMH-group, indicating that corticomedullary or deep WMH-distribution with minimal periventricular WMH suggests embolic etiologies.
Abstract
Background and Purpose: We investigated the correlation between the deep distribution of white matter hyperintensity (WMH) (dWMH: WMH in deep and corticomedullary areas, with minimal periventricular WMH) and a positive agitated saline contrast echocardiography result. Methods: We retrospectively recruited participants with comprehensive dementia evaluations, an agitated saline study, and brain imaging. The participants were classified into two groups according to WMH-distributions: dWMH and dpWMH (mainly periventricular WMH with or without deep WMH.) We hypothesized that dWMH is more likely associated with embolism, whereas dpWMH is associated with small-vessel diseases. We compared the clinical characteristics, WMH-distributions, and positive rate of agitated saline studies between the two groups. Results: Among 90 participants, 27 and 12 met the dWMH and dpWMH criteria, respectively. The dWMH-group was younger (62.2±7.5 vs. 78.9±7.3, p<0.001) and had a lower prevalence of hypertension (29.6% vs. 75%, p=0.008), diabetes mellitus (3.7% vs. 25%, p=0.043), and hyperlipidemia (33.3% vs. 83.3%, p=0.043) than the dpWMH-group. Regarding deep white matter lesions, the number of small lesions (<3 mm) was higher in the dWMH-group(10.9±9.7) than in the dpWMH-group (3.1±6.4) (p=0.008), and WMH was predominantly distributed in the border-zones and corticomedullary areas. Most importantly, the positive agitated saline study rate was higher in the dWMH-group than in the dpWMH-group (81.5% vs. 33.3%, p=0.003). Conclusions: The dWMH-group with younger participants had fewer cardiovascular risk factors, showed more border-zone-distributions, and had a higher agitated saline test positivity rate than the dpWMH-group, indicating that corticomedullary or deep WMH-distribution with minimal periventricular WMH suggests embolic etiologies.
참고문헌 (51)
- Peppiatt CM, "Bidirectional control of CNS capillary diameter by pericytes", Nature, 443, pp.700~704 (2006)
- Nishimura N, "Limitations of collateral flow after occlusion of a single cortical penetrating arteriole", J Cereb Blood Flow Metab, 30, pp.1914~1927 (2010)
- Kang SH, "Amyloid positivity in the Alzheimer", subcortical-vascular spectrum, 2021, pp.96, e2201~e2211
- Sarbu N, "White matter diseases with radiologic-pathologic correlation", Radiographics, 36, pp.1426~1447 (2016)
- Ye BS, "Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia", Neurology, 85, pp.1687~1693 (2015)
- Lee JH, "Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B", Neurology, 77, pp.18~25 (2011)
- Kim GH, "Seoul criteria for PiB(-)subcortical vascular dementia based on clinical and MRI variables", Neurology, 82, pp.1529~1535 (2014)
- Griffanti L, "Classification and characterization of periventricular and deep white matter hyperintensities on MRI : a study in older adults", Neuroimage, 170, pp.174~181 (2018)
- Oh Young Bang, "Patent Foramen Ovale and Stroke–Current Status", 대한뇌졸중영문학회지, 17(3), pp.229~237 (2015), 대한뇌졸중학회
- Kim BJ, "Imaging characteristics of ischemic strokes related to patent foramen ovale", Stroke, 44, pp.3350~3356 (2013)
- Boutet C, "Brain magnetic resonance imaging findings in cryptogenic stroke patients under 60 years with patent foramen ovale", Eur J Radiol, 83, pp.824~828 (2014)
- Kent DM, "An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke", Neurology, 81, pp.619~625 (2013)
- Knudsen KA, "Clinical diagnosis of cerebral amyloid angiopathy : validation of the Boston criteria", Neurology, 56, pp.537~539 (2001)
- Kim S, "Periventricular white matter hyperintensities and the risk of dementia : a CREDOS study", Int Psychogeriatr, 27, pp.2069~2077 (2015)
- 안현정, "Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients", Journal of Korean Medical Science, 25(7), pp.1071~1076 (2010), 대한의학회
- 강성훈, "The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum", Dementia and Neurocognitive Disorders(대한치매학회지), 18(3), pp.77~95 (2019), 대한치매학회[DOI]
- Attaran RR, "Protocol for optimal detection and exclusion of a patent foramen ovale using transthoracic echocardiography with agitated saline microbubbles", Echocardiography, 23, pp.616~622 (2006)
- Saric M, "Guidelines for the use of echocardiography in the evaluation of a cardiac source of embolism", J Am Soc Echocardiogr, 29, pp.1~42 (2016)
- Rodrigues AC, "Importance of adequately performed Valsalva maneuver to detect patent foramen ovale during transesophageal echocardiography", J Am Soc Echocardiogr, 26, pp.1337~1343 (2013)
- Carroll JD, "Closure of patent foramen ovale versus medical therapy after cryptogenic stroke", N Engl J Med, 368, pp.1092~1100 (2013)
- Clarke NR, "Transthoracic echocardiography using second harmonic imaging with Valsalva manoeuvre for the detection of right to left shunts", Eur J Echocardiogr, 5, pp.176~181 (2004)
- Altaf N, "Cerebral white matter hyperintense lesions are associated with unstable carotid plaques", Eur J Vasc Endovasc Surg, 31, pp.8~13 (2006)
- Inglese M, "Dilated perivascular spaces : hallmarks of mild traumatic brain injury", AJNR Am J Neuroradiol, 26, pp.719~724 (2005)
- Heier LA, "Large Virchow-Robin spaces : MR-clinical correlation", AJNR Am J Neuroradiol, 10, pp.929~936 (1989)
- Medrano Martorell S, "Hyperintense punctiform images in the white matter : a diagnostic approach", Radiologia(Madr), 54, pp.321~335 (2012)
- Kim KW, "Classification of white matter lesions on magnetic resonance imaging in elderly persons", Biol Psychiatry, 64, pp.273~280 (2008)
- Mahammedi A, "Small vessel disease, a marker of brain health : what the radiologist needs to know", AJNR Am J Neuroradiol, 43, pp.650~660 (2022)
- Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
- Greenberg SM, "Cerebral microbleeds : a guide to detection and interpretation", Lancet Neurol, 8, pp.165~174 (2009)
- Scheltens P, "Atrophy of medial temporal lobes on MRI in"probable"Alzheimer’s disease and normal ageing : diagnostic value and neuropsychological correlates", J Neurol Neurosurg Psychiatry, 55, pp.967~972 (1992)
- Wiggins ME, "Pilot investigation : older adults with atrial fibrillation demonstrate greater brain leukoaraiosis in infracortical and deep regions relative to non-atrial fibrillation peers", Front Aging Neurosci, 12, pp.271~ (2020)
- Ni L, "The asymmetry of white matter hyperintensity burden between hemispheres is associated with intracranial atherosclerotic plaque enhancement grade", Front Aging Neurosci, 12, pp.163~ (2020)
- Charidimou A, "White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy", Neurology, 86, pp.505~511 (2016)
- Purandare N, "Paradoxical embolisation and cerebral white matter lesions in dementia", Br J Radiol, 81, pp.30~34 (2008)
- Strambo D, "Embolic stroke of undetermined source and patent foramen ovale : risk of paradoxical embolism score validation and atrial fibrillation prediction", Stroke, 52, pp.1643~1652 (2021)
- Bergui M, "Selective vulnerability of cortical border zone to microembolic infarct", Stroke, 46, pp.1864~1869 (2015)
- Hwang TL, "Predilection of brain metastasis in gray and white matter junction and vascular border zones", Cancer, 77, pp.1551~1555 (1996)
- Meissner I, "Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography : the SPARC study. Stroke Prevention : Assessment of Risk in a Community", Mayo Clin Proc, 74, pp.862~869 (1999)
- Smith EE, "Prevention of stroke in patients with silent cerebrovascular disease : a scientific statement for healthcare professionals from the American Heart Association", American Stroke Association, 2017, pp.48, e44~e71
- Yoon CW, "Is antiplatelet treatment effective at attenuating the progression of white matter hyperintensities?", PLoS One, 12, pp.e0176300~ (2017)
- Mas JL, "Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke", N Engl J Med, 377, pp.1011~1021 (2017)
- Saver JL, "Long-term outcomes of patent foramen ovale closure or medical therapy after stroke", N Engl J Med, 377, pp.1022~1032 (2017)
- Søndergaard L, "Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke", N Engl J Med, 377, pp.1033~1042 (2017)
- Lee PH, "Cryptogenic stroke and high-risk patent foramen ovale : the DEFENSE-PFO trial", J Am Coll Cardiol, 71, pp.2335~2342 (2018)
- Hart RG, "Rivaroxaban for stroke prevention after embolic stroke of undetermined source", N Engl J Med, 378, pp.2191~2201 (2018)
- Hart RG, "Embolic strokes of undetermined source : the case for a new clinical construct", Lancet Neurol, 13, pp.429~438 (2014)
- Kasner SE, "Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source : a prespecified subgroup analysis from the NAVIGATE ESUS trial", Lancet Neurol, 17, pp.1053~1060 (2018)
- Carroll JD, "Closure of patent foramen ovale versus medical therapy after cryptogenic stroke", N Engl J Med, 368, pp.1092~1100 (2013)
- Ren P, "Diagnostic accuracy of transthoracic echocardiography for patent foramen ovale: a systematic review and meta-analysis", Heart, 98(Suppl 2), pp.E304~e304 (2012)[DOI]
- Wardlaw JM, "Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities", Neurology, 82, pp.1331~1338 (2014)
- Dickie DA, "Vascular risk factors and progression of white matter hyperintensities in the Lothian Birth Cohort 1936", Neurobiol Aging, 42, pp.116~123 (2016)